Navigate Global Drug Pricing with Confidence
From International Reference Pricing to US MFN policy, pharmaceutical pricing has never been more complex. At Symaptics, we built SyMAP—the AI-powered toolkit that cuts through the noise, delivering transparent models, explainable insights, and strategic clarity across your entire portfolio.
The SyMAP Platform
SyMAP is built to grow with your needs. Our modular platform currently includes IRP simulation and Medicaid GENEROUS modelling, with MFN analysis and more capabilities on the way. Explore the tools below.
Coming Soon
SyMAP IRP — International Reference Pricing with AI
Our flagship tool, SyMAP IRP, is a specialized AI-powered platform for International Reference Pricing simulation and analysis. Built specifically for pharmaceutical pricing and market access teams, SyMAP IRP combines rigorous IRP modelling with explainable AI to deliver transparent, actionable insights.
SyMAP GENEROUS — Medicaid MFN Simulation
SyMAP GENEROUS is an AI-powered implementation of the Medicaid GENEROUS Model, enabling pharmaceutical teams to simulate and analyze the potential impacts of policy changes on their portfolio. The GENEROUS model includes integrated MFN (Most Favored Nation) assessment capabilities to help you make informed strategic decisions with comprehensive scenario modelling and actionable insights.
SyMAP MFN — Most Favored Nation Drug Pricing Toolkit
Coming Soon
SyMAP MFN is our comprehensive toolkit for modelling Most Favored Nation (MFN) drug pricing across US government payer programs. As MFN policies reshape pharmaceutical pricing through international reference benchmarks, SyMAP MFN brings together the tools you need to analyse, simulate, and strategically respond to these evolving requirements—including the CMS GENEROUS Model for Medicaid, the proposed GUARD Model for Medicare Part B, and the GLOBE Model for Medicare Part D.
Custom AI Solutions
Looking for something beyond the platform? We build bespoke AI tools for pharmaceutical pricing and market access—whether that’s custom Excel add-ins, strategic assessments, or team training programmes.
Intelligent AI Toolkits
→
Advanced Data Solutions
→
AI Training Programs
→
Who We Are
Chris McDonald PhD
Founder
Chris brings over a decade of experience in pharmaceutical pricing and market access, with a strong background in both the pharmaceutical industry and consulting. Over the past five years, he has built extensive expertise developing IRP simulation models—work that now forms the foundation of SyMAP IRP—and is actively applying this experience to the rapidly evolving MFN sector.
Specializing in intelligent AI toolkits for pharmaceutical pricing and advanced data solutions for strategic market access insight, Chris develops bespoke AI-driven solutions that address complex challenges and deliver real value. With a commitment to purposeful AI integration, these tools are tailored to meet the unique needs of the pharmaceutical industry.
Client Feedback
A fantastic AI-powered tool, tailored to our specific needs as a market access consultancy. Chris was very professional and easy to work with, developing the tool on a tight timeline and with outputs that we were really happy with. Would recommend in a heartbeat.
The bespoke services provided by Symaptics significantly improved our market access efforts.
Get in Touch
Ready to transform your pharmaceutical pricing and market access strategy? Let’s discuss how SyMAP can help your team.